electroCore
company
About
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $34M
- Industries
- Health Care,Medical Device,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are for the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$34M
electroCore has raised a total of
$34M
in funding over 2 rounds. Their latest funding was raised on
Nov 29, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 29, 2017 | Series B | $34M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
electroCore is funded by 3 investors.
The Vinik Family Foundation
and Knoll Capital Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
